Statin Treatment Induced a Lipogenic Expression Hierarchical Network Centered by SREBF2 in the Liver
Statin treatment is a major prevention treatment for hypercholesterolemia and the management of patients with increased risk of cardiovascular disease (CVD) due to its protective effects. However, its long-term safety was questioned regarding its potential role in new-onset type 2 diabetes mellitus,...
Main Authors: | Shiyu Song, Mengyuan Niu, Qiao Liang, Lei Wang, Haiyan Min, Yuming Peng, Hongwei Wang, Qian Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.573824/full |
Similar Items
-
Analysis of MCM Proteins’ Role as a Potential Target of Statins in Patients with Acute Type A Aortic Dissection through Bioinformatics
by: Zheyong Liang, et al.
Published: (2021-03-01) -
Statin use is not associated with liver related mortality
by: Zahra Younoszai, et al.
Published: (2014-01-01) -
The Underutilization, Adverse Reactions and Efficacy of Statins after Liver Transplant: A Meta-Analysis and Systematic Review
by: Yeung Jek Ho, et al.
Published: (2021-07-01) -
Safety of statins
by: Debasish Maji, et al.
Published: (2013-01-01) -
Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis
by: Yue Gu, et al.
Published: (2019-12-01)